Blog
RSS FeedPosted by Michael Wonder on 11 Sep 2024
New medicine and an easier renewal process proposed for people with ADHD
12 September 2024 - PHARMAC is asking for feedback on two changes for people with attention deficit hyperactivity disorder - ...
Posted by Michael Wonder on 09 Sep 2024
First cancer medicine decision following PHARMAC funding boost
9 September 2024 - PHARMAC has decided to widen access to two medicines for several types of cancer. ...
Posted by Michael Wonder on 31 Aug 2024
New Zealand Pharmaceutical Schedule - 1 September 2024
1 September 2024 - The September 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 21 Aug 2024
PHARMAC proposes to widen access to medicine used in the treatment of heart failure
20 August 2024 - PHARMAC is consulting on plans to widen access to empagliflozin, a medicine used in the treatment ...
Posted by Michael Wonder on 09 Aug 2024
PHARMAC indicates interest in funding cancer treatment bevacizumab
9 August 2024 - PHARMAC is seeking commercial bids from suppliers for the supply of bevacizumab for a range of ...
Posted by Michael Wonder on 05 Aug 2024
Significant step forward proposed for bowel cancer
5 August 2024 - PHARMAC is looking to fund a medicine for bowel cancer that would help people live longer. ...
Posted by Michael Wonder on 01 Aug 2024
PHARMAC closes inactive medicine applications for greater clarity
1 August 2024 - PHARMAC has removed over 500 inactive medicine applications from its lists in the past five years ...
Posted by Michael Wonder on 01 Aug 2024
New Zealand Pharmaceutical Schedule - 1 August 2024
1 August 2024 - The August 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 19 Jul 2024
PHARMAC proposes to widen access to urinary tract infections treatment and fund a new epilepsy treatment
18 July 2024 - PHARMAC is consulting on improving access to treatment for urinary tract infections, as well as providing ...
Posted by Michael Wonder on 15 Jul 2024
PHARMAC proposal to increase access to five medicines for cancer and other health conditions
12 July 2024 - PHARMAC is looking to increase access to five medicines for a number of cancers, including kidney ...
Posted by Michael Wonder on 10 Jul 2024
Over 6,000 people will benefit from PHARMAC funding proposal if approved
10 July 2024 - PHARMAC plans to widen access to seven medicines benefitting over 6,000 people within the first 12 ...
Posted by Michael Wonder on 06 Jul 2024
Summary of consultation to widen access to cancer medicines and treatments to prevent fungal infections
5 July 2024 - PHARMAC is proposing to widen access to two medicines for cancer and two medicines for prevention ...
Posted by Michael Wonder on 05 Jul 2024
PHARMAC opens first consultation for cancer medicines after funding boost
5 July 2024 - PHARMAC is looking to widen access to four medicines as part of the first public consultation ...
Posted by Michael Wonder on 02 Jul 2024
Multiple myeloma treatments available to more people
2 July 2024 - PHARMAC is making more treatment options available for people with multiple myeloma and other blood disorders. ...
Posted by Michael Wonder on 30 Jun 2024
New Zealand Pharmaceutical Schedule - 1 July 2024
1 July 2024 - July 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...